• 

  Quadruple Misfolded Proteins May Explain Why Alzheimer’s Clinical Trials Have Failed
• 

  First FDA-Approved Diagnostic Agent to Detect Tau Tangles in Alzheimer’s Patients
• 

  A Common Asthma Drug Shows Promise as a Treatment for Alzheimer’s
• 

  Clearing Tau in Frontotemporal Dementia: Researchers Identify Target Protein
• 

  Losing Even Just One Night of Sleep May Trigger Alzheimer’s Biomarker
• 

  Tau Protein Drives Alzheimer’s More Than Beta-Amyloid, Study Says
• 

  Another Alzheimer’s Vaccine Moves Closer to Human Trials
• 

  Alzheimer’s Drug Targeting Tau Protein to Start New Clinical Trials
• 

  New ‘Basket’ Trials Target Dementia Through Precision Medicine
• 

  More Evidence An Eye Test Holds Clue To Alzheimer’s Risk
• 

  Frequent Daytime Napping May Be Early Warning Sign of Alzheimer’s
• 

  Alzheimer’s Tau Proteins Look Different and Spread Faster in Women Than in Men
• 

  Tau Proteins Spread More Easily in Aging Brains, Finds Study
• 

  Researchers Discover Brain Molecule, VPS35, Can Clear Alzheimer’s Tau Tangles
• 

  Alzheimer’s Tau Tangles More Likely to Accumulate in Women Than in Men

Previous123Next